How the tumor suppressor FBXW7 and the vitamin biotin together control whether a cancer cell can escape glutamine addiction. Based on Lisci et al., Molecular Cell 2026.
FBXW7 mutation: The tumor suppressor gene FBXW7 is lost or mutated — one of the most common tumor suppressor mutations in human cancers (colorectal, T-cell leukemia, cholangiocarcinoma, and others).
c-MYC accumulates: Without FBXW7, the oncogene c-MYC is no longer tagged for destruction by the proteasome. It builds up inside the cell to high levels, driving cancer growth programs.
Repressors silence PC (in nucleus): High c-MYC recruits a complex of transcriptional repressors — MAX, MNT, and SIN3A — into the nucleus, where they bind the pyruvate carboxylase (PC) gene promoter and shut off PC expression.
Biotin's route is blocked: Without PC protein, the vitamin biotin has no enzyme to activate. The pathway from pyruvate → oxaloacetate → TCA cycle (in the mitochondria) is closed.
Glutamine becomes essential: With the pyruvate anaplerosis route to the mitochondria closed, the cell must use glutamine (via GLS → α-ketoglutarate) as its only way to fuel the TCA cycle. It becomes glutamine addicted.
Therapeutic opportunity: FBXW7-mutant cancers that are glutamine-addicted may be specifically vulnerable to glutamine-starving therapies such as CB-839 (telaglenastat), a GLS1 inhibitor in clinical trials.
Based on: Lisci M, Vericel F, Liu Y, et al. (2026). Functional nutrient-genetic profiling reveals biotin and FBXW7 are essential to bypass glutamine addiction. Molecular Cell, 86(5):901–916.e10. PMID: 41747732. doi:10.1016/j.molcel.2026.02.002 · Retrieved from PubMed, National Library of Medicine.